AZACITIDINE Side Effects

7002632-3 | Chills, Dysuria, Escherichia Infection, Febrile Neutropenia, Headache, Klebsiella Infection, Micturition Urgency, Pollakiuria, Respiratory Failure
on Sep 17, 2010 Female patient from UNITED STATES , weighting 128.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dysuria, escherichia infection, febrile neutropenia, headache (What is headache?), klebsiella infection, micturition urgency, pollakiuria, respiratory failure. Azacitidine dosage: 75mg/m2 Qd Iv. During the same period patient was treated with REVLIMID (90 Mg Qd Po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6994609-9 | Clostridium Difficile Colitis, Disease Progression, Dyspnoea, Fatigue, Febrile Neutropenia, Lethargy, Metastatic Neoplasm, Pancytopenia, Pneumonia
Patient was taking Azacitidine (View Usage). Patient had the following side effects: clostridium difficile colitis, disease progression, dyspnoea, fatigue, febrile neutropenia, lethargy, metastatic neoplasm, pancytopenia, pneumonia (What is pneumonia?) on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 85.54 lb, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLIMID (Revlemid 50 Mg Qd Po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6994608-7 | Clostridium Difficile Colitis, Dyspnoea, Fatigue, Febrile Neutropenia, Lethargy, Malignant Neoplasm Progression, Pneumonia, Urinary Tract Infection Enterococcal
Adverse event was reported on Sep 16, 2010 by a Female patient taking Azacitidine (View Usage) (Dosage: Azacitidine 75 Mg/m2 Qd Iv) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 85.54 lb, After Azacitidine was administered, patient had the following side effects: clostridium difficile colitis, dyspnoea, fatigue, febrile neutropenia, lethargy, malignant neoplasm progression, pneumonia (What is pneumonia?), urinary tract infection enterococcal. During the same period patient was treated with REVLEMID 50MG (Revlemid 50 Mg Qd Po) (View Revlemid 50mg Review and Revlemid 50mg Label ).

6983466-2 | Blood Culture Positive, Constipation, Culture Urine Positive, Epistaxis, Fall, Headache, Hyperbilirubinaemia, Nausea, Platelet Count Decreased
on Sep 14, 2010 Female patient from UNITED STATES , weighting 131.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: blood culture positive, constipation (What is constipation?), culture urine positive, epistaxis, fall (What is fall?), headache (What is headache?), hyperbilirubinaemia, nausea (What is nausea?), platelet count decreased. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLIMID (Revlemid 50 Mg Qd Po) (View Revlimid Review and Revlimid Label ), PLEASE SEE 3 PAGE ATTACHMENT (View Please See 3 Page Attachment Review and Please See 3 Page Attachment Label ).


6962243-2 | Fatigue, Hypotension, Productive Cough, Sepsis
on Sep 01, 2010 Female patient from UNITED STATES , weighting 112.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient had the following side effects: fatigue, hypotension, productive cough, sepsis (What is sepsis?). Azacitidine dosage: 25mg/m2 Days 1-5/iv Q28d. During the same period patient was treated with REVLIMID (50mg/qd For 28 Days/po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6957782-4 | Diastolic Dysfunction, Febrile Neutropenia, Hypotension, Sinus Bradycardia
Patient was taking Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: diastolic dysfunction, febrile neutropenia, hypotension, sinus bradycardia on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 112.4 lb, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: 25mg/m2/days 1-5/iv Q28 Days. During the same period patient was treated with REVLIMID (50mg/qd For 28 Days/po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6938561-0 | Bronchopulmonary Aspergillosis, Myocardial Infarction, Sepsis
Adverse event was reported on Aug 18, 2010 by a Female patient taking Azacitidine (View Usage) (Dosage: ) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , 69 years of age, Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, myocardial infarction, sepsis (What is sepsis?). During the same period patient was treated with VORINOSTAT (View Vorinostat Review and Vorinostat Label ).

6933009-4 | Aortic Aneurysm, Haemoglobin Decreased, Platelet Count Decreased, Pyrexia, Thrombosis
on Aug 18, 2010 Male patient from UNITED STATES , 71 years of age, weighting 201.9 lb, was diagnosed with myelofibrosis and was treated with Azacitidine (View Usage). Patient had the following side effects: aortic aneurysm (What is aortic aneurysm?), haemoglobin decreased, platelet count decreased, pyrexia, thrombosis. Azacitidine dosage: 75mg/m2 Daily- Day 1-7 Subcutaneous. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), NEBIVOLOL HCL (BYSTOLIC) (View Nebivolol Hcl (bystolic) Review and Nebivolol Hcl (bystolic) Label ), OMEPRAZOLE MAGNESIUM (View Omeprazole Magnesium Review and Omeprazole Magnesium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6914838-X | Anaemia, Hypokalaemia, Myelodysplastic Syndrome, Renal Failure Acute
on Aug 04, 2010 Male patient from UNITED STATES , 71 years of age, was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: anaemia, hypokalaemia, myelodysplastic syndrome, renal failure acute. Azacitidine dosage: 116.2 Mg Other Iv. Patient was hospitalized.

6909491-5 | Interstitial Lung Disease
Patient was taking Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Jul 20, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, . Azacitidine dosage: . During the same period patient was treated with BROAD SPECTRUM ANTIBIOTICS (View Broad Spectrum Antibiotics Review and Broad Spectrum Antibiotics Label ). Patient was hospitalized.

6868895-X | Cough, Fatigue, Febrile Neutropenia, Fungal Infection, Hypoxia, Leukocytosis, Lung Consolidation, Nausea, Oropharyngeal Pain
Adverse event was reported on Jul 21, 2010 by a Female patient taking Azacitidine (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 137.8 lb, Patient had the following side effects: cough, fatigue, febrile neutropenia, fungal infection (What is fungal infection?), hypoxia, leukocytosis, lung consolidation, nausea (What is nausea?), oropharyngeal pain. During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6843903-0 | Blood Creatinine Increased
on Jul 14, 2010 Male patient from UNITED STATES , weighting 142.2 lb, was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: blood creatinine increased. Azacitidine dosage: 880 Mg. During the same period patient was treated with MS 275 (SNDX 275, ENTINOSTAT) (14 Mg) (View Ms-275 (sndx-275, Entinostat) Review and Ms-275 (sndx-275, Entinostat) Label ). Patient was hospitalized.

6836266-8 | Acute Myeloid Leukaemia Recurrent, Blood Culture Positive, Diarrhoea, Pancytopenia, Pyrexia, Retching
on Jul 12, 2010 Female patient from UNITED STATES , weighting 177.9 lb, was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia recurrent, blood culture positive, diarrhoea, pancytopenia, pyrexia, retching. Azacitidine dosage: 1000 Mg. During the same period patient was treated with MS 275 (SNDX 275, ENTINOSTAT) (16 Mg) (View Ms-275 (sndx- 275, Entinostat) Review and Ms-275 (sndx- 275, Entinostat) Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6822024-7 | Caecitis, Pneumonia
Patient was taking Azacitidine (View Usage). Patient had the following side effects: caecitis, pneumonia (What is pneumonia?) on Jun 28, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 171.1 lb, was diagnosed with hypothyroidism, hypercholesterolaemia and. Azacitidine dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), COQ10 (View Coq10 Review and Coq10 Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6795069-3 | Asthenia, Bradycardia, Dizziness Postural, Hypophagia, Hypotension
Adverse event was reported on Jun 24, 2010 by a Female patient taking Azacitidine (View Usage) (Dosage: Azacitidine 75 Mg/m2 Qd Iv) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 108.5 lb, After Azacitidine was administered, patient had the following side effects: asthenia, bradycardia, dizziness postural, hypophagia, hypotension. During the same period patient was treated with REVLIMID (Revlemid 50 Mg Qd Po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6781083-0 | Febrile Neutropenia, Hypoxia, Pneumonia, Transfusion Reaction
on Jun 17, 2010 Female patient from UNITED STATES , weighting 137.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, hypoxia, pneumonia (What is pneumonia?), transfusion reaction. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLEMID (Revlemid 50 Mg Qd Po) (View Revlemid Review and Revlemid Label ), PLEASE SEE 21 PAGE ATTACHMENT (View Please See 21 Page Attachment Review and Please See 21 Page Attachment Label ). Patient was hospitalized.

6781081-7 | Diarrhoea, Diarrhoea Haemorrhagic, Diarrhoea Infectious, Fatigue, Haemorrhage, Hypotension, Hypovolaemia
on Jun 17, 2010 Female patient from UNITED STATES , weighting 108.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient had the following side effects: diarrhoea, diarrhoea haemorrhagic, diarrhoea infectious, fatigue, haemorrhage, hypotension, hypovolaemia. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLIMID (Revlemid 50 Mg Qd Po) (View Revlimid Review and Revlimid Label ), PLEASE SEE 17 PAGE ATTACHMENT (View Please See 17 Page Attachment Review and Please See 17 Page Attachment Label ). Patient was hospitalized.

6765587-2 | Arteriospasm Coronary, Chest Pain, Electrocardiogram St Segment Elevation, Tachycardia, Thrombocytopenia
Patient was taking Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: arteriospasm coronary, chest pain (What is chest pain?), electrocardiogram st segment elevation, tachycardia, thrombocytopenia on Jun 10, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 112.4 lb, . Azacitidine dosage: 100mg, Daily, Iv. During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), CALCIUM CARBONATE/VITAMIN D (View Calcium Carbonate/vitamin D Review and Calcium Carbonate/vitamin D Label ). Patient was hospitalized.

6761780-3 | Haemoglobin Decreased, Staphylococcal Bacteraemia
Adverse event was reported on Jun 03, 2010 by a Male patient taking Azacitidine (View Usage) (Dosage: ) . Location: UNITED STATES , 83 years of age, weighting 184.3 lb, Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, staphylococcal bacteraemia. During the same period patient was treated with PXD 101 (View Pxd 101 Review and Pxd 101 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), RAMIPRIL/HYDROCHLOROTHIAZIDE (View Ramipril/hydrochlorothiazide Review and Ramipril/hydrochlorothiazide Label ).

6761775-X | Hypotension, Peritoneal Haemorrhage, Thrombocytopenia
on May 28, 2010 Female patient from UNITED STATES , weighting 101.4 lb, was diagnosed with myelodysplastic syndrome, thrombocytopenia, oral infection, transfusion, prophylaxis and was treated with Azacitidine (View Usage). Patient had the following side effects: hypotension, peritoneal haemorrhage, thrombocytopenia. Azacitidine dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TYLENOL (View Tylenol Review and Tylenol Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6734690-5 | Cholecystitis
on May 19, 2010 Male patient from UNITED STATES , 83 years of age, weighting 177.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: cholecystitis. Azacitidine dosage: 150 Mg Every Day Sq.

6731398-7 | Chills, Confusional State
Patient was taking Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: chills, confusional state on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 205.2 lb, was diagnosed with myelodysplastic syndrome and. Azacitidine dosage: 150 Mg Every Day Iv.

6721214-1 | Abdominal Distension, Activated Partial Thromboplastin Time Prolonged, Caecitis, Cardiac Enzymes Increased, Cardiac Failure Congestive, Cellulitis, Coagulopathy, Colonic Obstruction, Dry Mouth
Adverse event was reported on May 06, 2010 by a Male patient taking Azacitidine (View Usage) (Dosage: ) was diagnosed with hypothyroidism and. Location: UNITED STATES , weighting 171.1 lb, Patient had the following side effects: abdominal distension, activated partial thromboplastin time prolonged, caecitis, cardiac enzymes increased, cardiac failure congestive, cellulitis (What is cellulitis?), coagulopathy, colonic obstruction, dry mouth. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), COQ10 (View Coq10 Review and Coq10 Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6711487-3 | Anaemia, Febrile Neutropenia, Haemolysis, Thrombocytopenia, Transfusion Reaction
on May 04, 2010 Female patient from UNITED STATES , weighting 138.0 lb, was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: anaemia, febrile neutropenia, haemolysis, thrombocytopenia, transfusion reaction. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLIMID (Revlemid 25 Mg Qd Po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6699079-6 | Abdominal Distension, Caecitis, Cellulitis, Hypernatraemia, Hyponatraemia, Hypoxia, Neutropenic Colitis, Oedema Peripheral, Pleural Effusion
on Apr 21, 2010 Male patient from UNITED STATES , weighting 171.1 lb, was diagnosed with hypothyroidism and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, caecitis, cellulitis (What is cellulitis?), hypernatraemia, hyponatraemia, hypoxia, neutropenic colitis, oedema peripheral, pleural effusion. Azacitidine dosage: . During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), COQ10 (View Coq10 Review and Coq10 Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6649641-1 | Epistaxis, Gastrointestinal Haemorrhage, Hypotension, No Therapeutic Response, Platelet Count Decreased, Pneumonia, Pyrexia
Patient was taking Azacitidine (View Usage). Patient had the following side effects: epistaxis, gastrointestinal haemorrhage, hypotension, no therapeutic response, platelet count decreased, pneumonia (What is pneumonia?), pyrexia on Mar 24, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 240.5 lb, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLIMID (Revlemmid 25 Mg Qd Po) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6583595-1 | Sepsis
Adverse event was reported on Feb 13, 2010 by a Female patient taking Azacitidine (View Usage) (Dosage: Azacitidine 75 Mg/m2 Qd Iv) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 118.8 lb, After Azacitidine was administered, patient had the following side effects: sepsis (What is sepsis?). During the same period patient was treated with REVLIMID (Revlemmid 10 Mg Qd Po) (View Revlimid Review and Revlimid Label ).

6573950-8 | Unevaluable Event
on Feb 04, 2010 Male patient from UNITED STATES , weighting 241.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event. Azacitidine dosage: 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLEMMID (25 Mg Qd Po) (View Revlemmid Review and Revlemmid Label ). Patient was hospitalized.

6569738-4 | Asthenia, Dizziness, Extrasystoles, Fall, Fatigue, Feeling Abnormal, Presyncope, Sinus Bradycardia
on Feb 02, 2010 Male patient from UNITED STATES , weighting 203.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), extrasystoles, fall (What is fall?), fatigue, feeling abnormal, presyncope, sinus bradycardia. Azacitidine dosage: Azacitidine 75 Mg/m2 Qd Iv. During the same period patient was treated with REVLEMID (Revlemid 10 Mg Qd Po) (View Revlemid Review and Revlemid Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ZOFRAN (View Zofran Review and Zofran Label ), PROCHLORPERAZINE (COMPAZINE) (View Prochlorperazine (compazine) Review and Prochlorperazine (compazine) Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6538729-1 | Diarrhoea, Nausea, Pyrexia
Patient was taking Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: diarrhoea, nausea (What is nausea?), pyrexia on Jan 14, 2010 from UNITED STATES Additional patient health information: Male patient , 84 years of age, weighting 196.2 lb, was diagnosed with myelodysplastic syndrome and. Azacitidine dosage: . Patient was hospitalized.

6534975-1 | Pancytopenia
Adverse event was reported on Jan 11, 2010 by a Male patient taking Azacitidine (View Usage) (Dosage: 176 Mg Iv Daily X 5) . Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: pancytopenia. Patient was hospitalized.

6449960-8 | Catheter Site Haemorrhage, Constipation, Diarrhoea, Epistaxis, Febrile Neutropenia, Haemorrhoidal Haemorrhage, Rash Erythematous, Rash Pruritic
on Nov 20, 2009 Male patient from UNITED STATES , weighting 175.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient had the following side effects: catheter site haemorrhage, constipation (What is constipation?), diarrhoea, epistaxis, febrile neutropenia, haemorrhoidal haemorrhage, rash erythematous, rash pruritic. Azacitidine dosage: 75 Mg/m2 Qd S/c. During the same period patient was treated with LENALIDOMIDE (10 Mg Qd Po) (View Lenalidomide Review and Lenalidomide Label ), DUCOSATE (COLACE) (View Ducosate (colace) Review and Ducosate (colace) Label ), ZYLOPRIM (View Zyloprim Review and Zyloprim Label ), METOPROLOL (LOPRESSOR) (View Metoprolol (lopressor) Review and Metoprolol (lopressor) Label ), IMDUR (View Imdur Review and Imdur Label ), PROSCAR (View Proscar Review and Proscar Label ), DESYREL (View Desyrel Review and Desyrel Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6417191-3 | Febrile Neutropenia
on Oct 27, 2009 Male patient from UNITED STATES , 66 years of age, weighting 201.9 lb, was diagnosed with neoplasm and was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: febrile neutropenia. Azacitidine dosage: 150 Mg Every Day Iv. Patient was hospitalized.

6303680-9 | Abscess, Acute Myeloid Leukaemia, Asthenia, Atrial Flutter, Decreased Appetite, Febrile Neutropenia, Haemoglobin Decreased, Lobar Pneumonia, Malignant Neoplasm Progression
Patient was taking Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), acute myeloid leukaemia, asthenia, atrial flutter, decreased appetite, febrile neutropenia, haemoglobin decreased, lobar pneumonia, malignant neoplasm progression on Aug 07, 2009 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: 150mg Iv X 5d 5/11-5/15. Patient was hospitalized.

6299671-7 | Febrile Neutropenia, Lymph Node Pain, Pneumonia, Pyrexia, Respiratory Rate Increased, Viral Pericarditis
Adverse event was reported on Aug 05, 2009 by a Male patient taking Azacitidine (View Usage) (Dosage: 75mg/m2 Qd S/c) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 130.3 lb, Patient had the following side effects: febrile neutropenia, lymph node pain, pneumonia (What is pneumonia?), pyrexia, respiratory rate increased, viral pericarditis.

6287721-3 | Febrile Neutropenia, Respiratory Rate Increased, Viral Pericarditis
on Jul 27, 2009 Male patient from UNITED STATES , weighting 130.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: febrile neutropenia, respiratory rate increased, viral pericarditis. Azacitidine dosage: 75mg/m2, Qd, S/c. Patient was hospitalized.

6265745-X | Contusion, Febrile Neutropenia, Hyperhidrosis, Jaundice, Oedema Peripheral, Oxygen Saturation Decreased, Rales, Respiratory Rate Increased
on Jul 09, 2009 Male patient from UNITED STATES , weighting 175.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, febrile neutropenia, hyperhidrosis, jaundice (What is jaundice?), oedema peripheral, oxygen saturation decreased, rales, respiratory rate increased. Azacitidine dosage: 75mg/m2 Qd S/c. During the same period patient was treated with LENALIDOMIDE (5 Mg Qd Po) (View Lenalidomide Review and Lenalidomide Label ). Patient was hospitalized.

6258114-X | Febrile Neutropenia, Hyperhidrosis, Oedema Peripheral, Oxygen Saturation Decreased, Respiratory Rate Increased
Patient was taking Azacitidine (View Usage). Patient had the following side effects: febrile neutropenia, hyperhidrosis, oedema peripheral, oxygen saturation decreased, respiratory rate increased on Jul 02, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 175.7 lb, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: 75mg/m2 Qd S/c. During the same period patient was treated with LENALIDOMIDE (5 Mg Qd Po) (View Lenalidomide Review and Lenalidomide Label ). Patient was hospitalized.

6247064-0 | Blood Phosphorus Decreased, Muscle Spasms, Muscle Twitching
Adverse event was reported on Jun 24, 2009 by a Female patient taking Azacitidine (View Usage) (Dosage: 75mg/m2 Iv Qd X 5d) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 56 years of age, weighting 163.1 lb, After Azacitidine was administered, patient had the following side effects: blood phosphorus decreased, muscle spasms, muscle twitching. During the same period patient was treated with SENNA (View Senna Review and Senna Label ), PREVACID (View Prevacid Review and Prevacid Label ), DOCUSATE (View Docusate Review and Docusate Label ), CLARITIN (View Claritin Review and Claritin Label ), DAPSONE (View Dapsone Review and Dapsone Label ), LEVOFLOX (View Levoflox Review and Levoflox Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

6244311-6 | Acute Respiratory Distress Syndrome, Pneumonia, Systemic Inflammatory Response Syndrome, Tachycardia
on Jun 23, 2009 Female patient from UNITED STATES , weighting 169.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, pneumonia (What is pneumonia?), systemic inflammatory response syndrome, tachycardia. Azacitidine dosage: 75mg/m2 Qd S/c. During the same period patient was treated with BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), ACCOLATE (View Accolate Review and Accolate Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PREVACID (View Prevacid Review and Prevacid Label ), METPHORMIN (View Metphormin Review and Metphormin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ). Patient was hospitalized.

6242350-2 | Febrile Neutropenia, Pneumonia
on Jun 22, 2009 Male patient from UNITED STATES , weighting 183.0 lb, was treated with Azacitidine (View Usage). Patient had the following side effects: febrile neutropenia, pneumonia (What is pneumonia?). Azacitidine dosage: 150 Mg X 5 Days Q28 Iv. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMMONIUM LACTATE (View Ammonium Lactate Review and Ammonium Lactate Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), DOCUSATE NA (View Docusate Na Review and Docusate Na Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), LORATADINE (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

6217715-5 | Performance Status Decreased, Pyrexia, Rales
Patient was taking Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: performance status decreased, pyrexia, rales on Jun 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 169.3 lb, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: 75mg/m2 Qd S/c. Patient was hospitalized.

6189590-9 | Intestinal Perforation
Adverse event was reported on May 01, 2009 by a Male patient taking Azacitidine (View Usage) (Dosage: ) . Location: AUSTRALIA , weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: intestinal perforation. During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), PRAZSOIN HCL (View Prazsoin Hcl Review and Prazsoin Hcl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TIOTROPIUM (View Tiotropium Review and Tiotropium Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ). Patient was hospitalized.

6157653-X | Chronic Myelomonocytic Leukaemia, Pneumonia
on Apr 10, 2009 Female patient from UNITED STATES , 68 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Azacitidine (View Usage). Patient had the following side effects: chronic myelomonocytic leukaemia, pneumonia (What is pneumonia?). Azacitidine dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), EPOGEN (View Epogen Review and Epogen Label ).

6152711-8 | Haemorrhage, Hypotension, Thrombocytopenia
on Apr 01, 2009 Female patient from UNITED STATES , weighting 101.4 lb, was diagnosed with myelodysplastic syndrome, oral infection, transfusion, prophylaxis, pruritus and was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: haemorrhage, hypotension, thrombocytopenia. Azacitidine dosage: . During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TYLENOL (View Tylenol Review and Tylenol Label ), ATIVAN (View Ativan Review and Ativan Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

6141111-2 | Abscess Limb, Cellulitis, Haematuria, Joint Abscess, Pitting Oedema, Thrombocytopenia
Patient was taking Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: abscess limb, cellulitis (What is cellulitis?), haematuria, joint abscess, pitting oedema, thrombocytopenia on Apr 01, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 170.0 lb, was diagnosed with acute myeloid leukaemia and. Azacitidine dosage: 100 Mg/m2 Iv Q 4 Weeks. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ). Patient was hospitalized.

6087236-1 | Caecitis
Adverse event was reported on Jan 09, 2009 by a Male patient taking Azacitidine (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 210.2 lb, Patient had the following side effects: caecitis. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN (View Gemtuzumab Ozogamicin Review and Gemtuzumab Ozogamicin Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6086794-0 | Caecitis
on Jan 09, 2009 Male patient from UNITED STATES , weighting 210.2 lb, was treated with Azacitidine (View Usage). After Azacitidine was administered, patient had the following side effects: caecitis. Azacitidine dosage: . During the same period patient was treated with GEMTUZUMAB OZOGAMICIN (View Gemtuzumab Ozogamicin Review and Gemtuzumab Ozogamicin Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6085701-4 | Acute Myocardial Infarction, Hypoxia, Organ Failure, Pneumonia, Septic Shock
on Feb 17, 2009 Male patient from KOREA, REPUBLIC OF , weighting 165.6 lb, was treated with Azacitidine (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, hypoxia, organ failure, pneumonia (What is pneumonia?), septic shock. Azacitidine dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CALCIUM POLYCARBOPHIL (View Calcium Polycarbophil Review and Calcium Polycarbophil Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), SOLIFENACIN SUCCINATE (View Solifenacin Succinate Review and Solifenacin Succinate Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ).

6071845-X | Haemorrhage, Hypotension, Peritoneal Haemorrhage, Post Procedural Haemorrhage, Thrombocytopenia
Patient was taking Azacitidine (View Usage). Patient had the following side effects: haemorrhage, hypotension, peritoneal haemorrhage, post procedural haemorrhage, thrombocytopenia on Jan 29, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 101.4 lb, was diagnosed with myelodysplastic syndrome, infection (What is infection?), nausea (What is nausea?), insomnia, pain (What is pain?) and. Azacitidine dosage: . During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), POTASSIUM PHOSPHATES (View Potassium Phosphates Review and Potassium Phosphates Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), AMBIEN (View Ambien Review and Ambien Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), MAGNESIUM TAB SR (View Magnesium Tab Sr Review and Magnesium Tab Sr Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.